Antianaphylactic properties of eugenol

Pharmacological Research

Volumn 36, Issue 6, 1997, Pages 475-480

  Kim, Hyung Min ^a   Lee, Eun Hee ^a   Kim, Chang Young ^a   Chung, Jong Gab ^b   Kim, Sang Hyun ^c   Lim, Jong Pil ^c   Shin, Tae Yong ^c  

^a Wonkwang University   (South Korea)

^b Wonkwang Health Science University   (South Korea)

^c Woosuk University   (South Korea)

Author keywords

Anaphylaxis; Eugenol; Histamine; Mast cells; Tumor necrosis factor

Indexed keywords

COMPOUND 48-80; DINITROPHENYL ANTIBODY; EUGENOL; HISTAMINE; LOCAL ANESTHETIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; HISTAMINE BLOOD LEVEL; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT;

EID: 0031474273     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0256     Document Type: Article

References (23)

1. 1. IARC Monographs, Evaluation of the carcinogenic risk of chemicals to humans. Vol. 36, Lyon, France, 1985: pp. 75-97.
2. 2. Wasserman SI, Marquardt DL. Anaphylaxis in Allergy: Principles and Practice. 3rd ed. St. Louis: C.V. Mosby Co., 1988.
3. 3. Petersen LJ, Mosbech H, Skov P. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J Allergy Clin Immunol 1996; 97: 672-9.
4. 4. Lagunof D, Martin TW Read G. Agents that release histamine from mast cells. Annu Rev Pharmacol Toxicol 1983; 23: 331-51.
5. 5. Ennis M, Pearce FL, Weston PM. Some studies on the release of histamine from mast cells stimulated with polylysine. Br J Phamacol 1980; 70: 329-34.
6. 6. Baltzly R, Buck JS, De Beer EJ, Webb FS. A family of long acting depressors. J Am Chem Soc 1949; 71: 1301-5.
7. 7. Paton WDM Compound 48/80: a potent histamine liberator. Br J Phamacol 1951; 6: 499-508.
8. 8. Allansmith MR, Baird RS, Ross RN, Barney NP, Bloch KJ. Ocular anaphylaxis induced in the rat by topical application of compound 48/80. Dose response and time course study. Acta Ophthalmol 1989; 67: 145-53.
9. 9. Segal DM, Taurog J, Metzger H. Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. Proc Natl Acad Sci USA 1977; 74: 2993-7.
10. 10. Metzger H, Alcaraz G, Hohman R, Kinet JP, Pribluda V, Quarto R. The receptor with high affinity for immunoglobulin E. Annu Rev Immunol 1986; 4: 419-70.
11. 11. Alber G, Miller L, Jelsema C, Varin-Blank N, Metzger H. Structure/function relationships in the mast cell high-affinity receptor for IgE (FcRI): Role of cytoplasmic domains. J Biol Chem 1991; 266: 22613-20.
12. 12. Saito H, Nomura Y. Screening methods for durg evaluation 3. In: Suzuki L, Tanaka H, Yajima H, Fukuda H, Sezaki H, Koga K, Hirobe M, Nakajime T. eds. Pharmaceutical Research and Development. Tokyo: Hirokawa, 1989: p. 22.
13. 13. Gordon JR, Galli SJ. Mast cell as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990; 346: 274-6.
14. 14. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordon RP, Paul WE. Mast cell lines produce limphokines in response to cross-linkage of FcRI or to calcium ionophores. Nature 1989; 339: 64-7.
15. 15. Wodnar-filipowicz A, Heusser CH, Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989; 339: 150-2.
16. 16. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME. Interleukin 3-dependent and-independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989; 170: 245-57.
17. 17. Gurish MF, Ghildyal N, Arm J, Austen KF, Avraham S, Reynolds DS, Stevens RL. Cytokine mRNA are preferentially increased relative to secretory granule protein mRNA in mouse bone marrow-derived mast cells that have undergone IgE-mediated activation and degranulation. J Immunol 1991; 146: 1527-33.
18. 18. Katayama S, Shionoya H, Ohtake S. A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol Immunol 1978; 22: 89-101.
19. 19. Shore PA, Burkhalter A, Cohn, VH. A method for fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 1959; 127: 182-6.
20. 20. Kanemoto, TJ, Kasugai T, Yamatodani A, Ushio H, Mochizuki T, Tohya K, Kimura M, Nishimura M, Kitamura Y. Supernormal histamine release and normal cytotoxic activity of Beige rat mast cells with giant granules. Int Arch Allergy Immunol 1993; 100: 99-106.
21. 21. Yurt RW, Leid RW, Austen KF. Native heparin from rat peritoneal mast cells. J Biol Chem 1977; 252: 518-21.
22. 22. Scuderi P, Sterling RE, Lam KS, Finley PR, Ryan KJ, Ray CG, Petersen E, Slymen DJ, Salmon SE. Raised serum levels of tumor necrosis factor in parasitic infections. Lancet 1986; 2: 1364-5.
23. 23. Tasaka K, Mio M, Okamoto M. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann Allergy 1986; 56: 464-9.